Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 5/20 | 0.73 |
| ▸ | DAO | P14920 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.50 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.50 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.50 |
| ▸ | ITGB3 | P05106 | 6/20 | 0.49 |
| ▸ | ITGA2B | P08514 | 6/20 | 0.49 |
| ▸ | F10 | P00742 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.42 |
| ▸ | SLC6A13 | Q9NSD5 | 1/20 | 0.42 |
| ▸ | GABRP | O00591 | 1/20 | 0.42 |
| ▸ | GABRD | O14764 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.42 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.42 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.42 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.42 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3441470 | 0.98 | PNMT (0.71) | PNMTDAOALDH1A1TPSAB1TPSD1 | |
| Trifluoroacetic Acid SCHEMBL8457040 | 0.91 | PNMT (0.62) | PNMTDAOALDH1A1TPSAB1TPSD1 | |
| SCHEMBL6421249 | 0.90 | ALDH1A1 (0.65) | PNMTDAOALDH1A1TPSAB1TPSD1 | |
| SCHEMBL11174836 | 0.88 | ALDH1A1 (0.66) | PNMTDAOALDH1A1TPSAB1TPSD1 | |
| SCHEMBL1173969 | 0.86 | ALDH1A1 (0.59) | PNMTDAOALDH1A1TPSAB1TPSD1 | |
| SCHEMBL6421837 | 0.85 | PNMT (1.00) | PNMTDAOALDH1A1TPSAB1TPSD1 | |
| SCHEMBL977061 | 0.84 | PNMT (0.70) | PNMTDAOALDH1A1TPSAB1TPSD1 | |
| Hydrochloric Acid SCHEMBL6421343 | 0.83 | PNMT (0.68) | PNMTDAOALDH1A1TPSAB1TPSD1 | |
| Hydrochloric Acid SCHEMBL19712091 | 0.82 | ALDH1A1 (0.53) | PNMTDAOALDH1A1TPSAB1TPSD1 | |
| SCHEMBL28533972 | 0.81 | PNMT (0.70) | PNMTALDH1A1TPSAB1TPSD1TPSG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190055260-A1 | OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF | JIANGSU VCARE PHARMATECH CO., LTD. (CN) | 2019-02-21 | — | — | US | claimed |
| US-20130165476-A1 | OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF | JIANGSU VCARE PHARMATECH CO., LTD. (CN) | 2013-06-27 | — | — | US | claimed |
| EP-2532668-A1 | OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF | Jiangsu Vcare Pharmatech Co., Ltd (CN) | 2012-12-12 | — | — | EP | claimed |
| JP-63002992-A | — | — | None | — | — | JP | disclosed |
| EP-3290423-B1 | OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF | JIANGSU VCARE PHARMATECH CO LTD (CN) | 2021-07-21 | — | — | EP | disclosed |
| WO-2021113686-A1 | MASP-2 INHIBITORS AND METHODS OF USE | OMEROS CORPORATION (US) | 2021-06-10 | — | — | WO | disclosed |
| US-20190055260-A1 | OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF | JIANGSU VCARE PHARMATECH CO., LTD. (CN) | 2019-02-21 | — | — | US | disclosed |
| US-10000506-B2 | Optically active 2-hydroxy tetrahydrothienopyridine derivatives, preparation method and use in manufacture of medicament thereof | JIANGSU VCARE PHARMATECH CO., LTD. (CN) | 2018-06-19 | — | — | US | disclosed |
| EP-3290423-A1 | OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF | Jiangsu Vcare Pharmatech Co., Ltd (CN) | 2018-03-07 | — | — | EP | disclosed |
| EP-2532668-B1 | OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF | JIANGSU VCARE PHARMATECH CO LTD (CN) | 2017-05-24 | — | — | EP | disclosed |
| US-20170121341-A1 | OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF | JIANGSU VCARE PHARMATECH CO., LTD. (CN) | 2017-05-04 | — | — | US | disclosed |
| US-6407112-B1 | 2A,3,4,5-TETRAHYDRO-1H-BENZ(CD)INDOL-2-ONE DERIVATIVES; 5-HYDROXYTRYPTAMINE AGONISTS; SLEEP, CIRCADIAN RHYTHYM, BIPOLAR, AND PSYCHOLOGICAL DISORDER TREATMENT | MEIJI SEIKA KAISHA, LTD. (JP) | 2002-06-18 | — | — | US | disclosed |
| EP-1081136-A1 | OPTICALLY ACTIVE TETRAHYDROBENZINDOLE DERIVATIVES | Meiji Seika Kaisha, Ltd. (JP) | 2001-03-07 | — | — | EP | disclosed |
| EP-1057814-A1 | TETRAHYDROBENZINDOLE DERIVATIVES | Meiji Seika Kaisha, Ltd. (JP) | 2000-12-06 | — | — | EP | disclosed |
| JP-2000273097-A | PRODUCTION OF 4,5,6,7-TETRAHYDROTHIENO[3,2c]PYRIDINE-2- CARBOXYLIC ACID DERIVATIVE | FUJI PHOTO FILM CO LTD | 2000-10-03 | — | — | JP | disclosed |
| EP-0641770-B1 | NOVEL COMPOUND WITH PLATELET AGGREGATION INHIBITOR ACTIVITY | MEIJI SEIKA CO (JP) | 1998-05-13 | — | — | EP | disclosed |
| US-5698692-A | INHIBIT BINDING BETWEEN PLATELET MEMBRANE GLYCOPROTEIN AND FIBRINOGEN | MEIJI SEIKA KABUSHIKI KAISHA (JP) | 1997-12-16 | — | — | US | disclosed |
| US-5594004-A | CARDIOVASCULAR DISORDERS AND ANTICOAGULANTS | MEIJI SEIKA KABUSHIKI KAISHA (JP) | 1997-01-14 | — | — | US | disclosed |
| EP-0641770-A1 | NOVEL COMPOUND WITH PLATELET AGGREGATION INHIBITOR ACTIVITY | MEIJI SEIKA KABUSHIKI KAISHA (JP) | 1995-03-08 | — | — | EP | disclosed |
| JP-S632992-A | THIENO(3,2-C)PYRIDINE DERIVATIVE AND PRODUCTION THEREOF | DAITO KOEKI KK | 1988-01-07 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10000506-B2 | Optically active 2-hydroxy tetrahydrothienopyridine derivatives, preparation method and use in manufacture of medicament thereof | TFPI, DHPS, THPO | PNMT 172/4885DAO 1442/4885ALDH1A1 186/4885 |
| US-20130165476-A1 | OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF | TFPI, DHPS, THPO | PNMT 172/4885DAO 1442/4885ALDH1A1 186/4885 |
| US-20170121341-A1 | OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF | TFPI, DHPS, THPO | PNMT 172/4885DAO 1442/4885ALDH1A1 186/4885 |
| US-20190055260-A1 | OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF | TFPI, DHPS, THPO | PNMT 172/4885DAO 1442/4885ALDH1A1 186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.